Skip to main content

Fluidigm Advanta CFTR NGS Library Prep Assay

Fluidigm has launched the Advanta CFTR NGS Library Prep Assay, a next-generation sequencing library prep workflow for sequencing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Developed for use with the company's Juno system, the assay automates target enrichment of CFTR variants from each of the gene's 27 exons and selected intronic regions using microfluidic technology. The assay can produce 48 to 1,500 or more NGS libraries each week from DNA derived from blood, saliva, or buccal swabs. Each integrated microfluidic circuit features open inlets to simplify the addition of new assay over time, the company said.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.